Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Rashed Al Banna"'
Publikováno v:
ADMET and DMPK (2021)
Background: Pharmacokinetics of warfarin has not been described in our population. We derived the pharmacokinetic parameters from a validated pharmacokinetic-pharmacodynamic model. Methods: Patients receiving warfarin for at least 6 months were recru
Externí odkaz:
https://doaj.org/article/22511aac908a4e3ebce2523ebb7dfcd7
Autor:
Mohammad Zubaid, Wafa Rashed, Mustafa Ridha, Mohammad Al-Jarallah, Adel Hamad, Rashed Al Banna, Kadhim Sulaiman, Nooshin Bazargani, Wael Almahmeed, Arif Al Mulla, Fahad Baslaib, Nidal Asaad, Sreeja Attur
Publikováno v:
Heart Views, Vol 19, Iss 3, Pp 81-84 (2018)
Aim: The aim of this study is to describe the clinical characteristics of ambulatory patients with chronic heart failure (HF) in the Arabian Gulf and to examine several aspects including types of HF, causes, and adherence to management guidelines. Me
Externí odkaz:
https://doaj.org/article/9e11bc5c9ae043aeb004488543f54c41
Publikováno v:
Current Drug Safety. 18:23-30
Aims: To identify the extent and associated factors for patients with prolonged prothrombin time, international normalized ratio (PT-INR), and the dosage modifications were carried out with warfarin. Background: Studies evaluating patients on warfari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17de7c34a492208f5462f61f65031a84
https://doi.org/10.2174/1574886317666220429103847
https://doi.org/10.2174/1574886317666220429103847
Publikováno v:
European Journal of Hospital Pharmacy. 30:41-45
Background The literature regarding the seasonal variation in the therapeutic response to warfarin is somewhat contradictory, with several discrepancies. We assessed the influence of seasons on various pharmacodynamic indices of warfarin. Methods A r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fecf27b5ea9443873212a0ca8f54003e
https://doi.org/10.1136/ejhpharm-2021-002793
https://doi.org/10.1136/ejhpharm-2021-002793
Autor:
Zainab H. Malalla, Rashed Al Banna, Mai S. Sater, Ghufran Jassim, Kannan Sridharan, Sameer Otoom, Aysha Husain
Publikováno v:
Pharmacological Reports. 73:1405-1417
Warfarin is the most commonly evaluated drug in pharmacogenetic-guided dosing studies. However, gaps remain regarding the influence of the genetic polymorphisms of CYP2C9, VKORC1, and CYP4F2 on specific pharmacodynamic parameters like the warfarin se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c2794932f1d72e205208849d2c62ce7
https://doi.org/10.1007/s43440-021-00256-w
https://doi.org/10.1007/s43440-021-00256-w
Publikováno v:
International journal of clinical pharmacy.
Machine learning algorithms (MLAs) carry a huge potential in identifying predicting factors and are being explored for their utility in the field of personalized medicine.We aimed to investigate MLAs for identifying predictors (clinical and genetic)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab98060399c0b35cfdbd7f6152bdb69
https://pubmed.ncbi.nlm.nih.gov/36306062
https://pubmed.ncbi.nlm.nih.gov/36306062
Autor:
Kannan, Sridharan, Rashed, Al Banna, Zainab, Malalla, Aysha, Husain, Mai, Sater, Ghufran, Jassim, Sameer, Otoom
Publikováno v:
Pharmacological reports : PR. 73(5)
Warfarin is the most commonly evaluated drug in pharmacogenetic-guided dosing studies. However, gaps remain regarding the influence of the genetic polymorphisms of CYP2C9, VKORC1, and CYP4F2 on specific pharmacodynamic parameters like the warfarin se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e38a5e2dbfbc1755037b1d8b4dcb0d48
https://pubmed.ncbi.nlm.nih.gov/33811620
https://pubmed.ncbi.nlm.nih.gov/33811620
Publikováno v:
ADMET and DMPK (2021)
ADMET and DMPK
Volume 9
Issue 2
ADMET and DMPK
Volume 9
Issue 2
Background: Pharmacokinetics of warfarin has not been described in our population. We derived the pharmacokinetic parameters from a validated pharmacokinetic-pharmacodynamic model. Methods: Patients receiving warfarin for at least 6 months were recru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21628e8150fe77576ec2a6b22f8d032b
https://www.pub.iapchem.org/ojs/index.php/admet/article/view/909
https://www.pub.iapchem.org/ojs/index.php/admet/article/view/909
Publikováno v:
Expert review of cardiovascular therapy. 18(11)
Warfarin exhibits huge inter-individual variability in therapeutic response. We assessed the extent and the factors affecting inter-individual variability in the anticoagulation control using pre-validated pharmacodynamic indices.Patients receiving w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574c4c058f8dafebdf713a933c597717
https://pubmed.ncbi.nlm.nih.gov/32820971
https://pubmed.ncbi.nlm.nih.gov/32820971
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES. 46(1)
WHAT IS KNOWN AND OBJECTIVES The changes in the therapeutic effect of warfarin during Ramadan fasting are controversial. Hence, we carried out the present study to assess if there are any alterations in the anticoagulation response to warfarin and id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a280a944d245b769c04b22a33c977eb5
https://pubmed.ncbi.nlm.nih.gov/32926452
https://pubmed.ncbi.nlm.nih.gov/32926452